ETX 101Alternative Names: ETX-101
Latest Information Update: 01 Dec 2015
At a glance
- Originator ETX Pharma
- Class Small molecules
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Diabetic gastroparesis; Gastroparesis
Most Recent Events
- 01 Dec 2015 Phase-III clinical trials in Gastroparesis in USA (PO)
- 01 Dec 2015 Phase-III clinical trials in Diabetic gastroparesis in USA (PO)